Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey

LL Howell and LD Byrd

Yerkes Regional Primate Research Center, Emory University, Atlanta, Georgia.

The behavioral effects of cocaine and GBR 12909, a highly selective dopamine uptake inhibitor, were compared in squirrel monkeys trained to respond under a fixed-interval schedule of stimulus termination and a second-order schedule of drug self-administration. Both drugs exhibited similar pharmacological profiles; intermediate doses increased response rates markedly and higher doses decreased response rates below control values. The magnitude of the rate-increasing effect was similar for cocaine and GBR 12909, although cocaine was approximately 3 times more potent. In contrast, the direct-acting dopamine agonists, SKF 38393 and quinpirole, produced only decreases in response rates. When cocaine and GBR 12909 were studied in combination with dopamine antagonists, the effects of either on fixed-interval performance were attenuated in a similar manner by a D1-selective antagonist (SCH 23390) and a D2- selective antagonist (spiperone), indicating the involvement of both D1 and D2 receptor subtypes. In contrast, an alpha 1-selective antagonist (prazosin) did not alter the dose-effect curve for cocaine or GBR 12909 in a manner that indicated a pharmacological antagonism. When doses of cocaine were administered in combination with GBR 12909, the effects on behavior were additive. However, the combined effects of cocaine and SKF 38393 or cocaine and quinpirole were more complex and did not appear to be additive. When the cocaine or GBR 12909 was self- administered under a second-order, fixed-interval schedule of drug injection, schedule-appropriate responding was maintained and the potency difference between the two drugs was comparable to that observed under the stimulus-termination schedule.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 258, Issue 1, pp. 178-185, 07/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				L. L. Howell, F. I. Carroll, J. R. Votaw, M. M. Goodman, and H. L. Kimmel Effects of Combined Dopamine and Serotonin Transporter Inhibitors on Cocaine Self-Administration in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 757 - 765. [Abstract] [Full Text] [PDF]

				P. W. Czoty, C. R. Ramanathan, N. H. Mutschler, A. Makriyannis, and J. Bergman Drug Discrimination in Methamphetamine-Trained Monkeys: Effects of Monoamine Transporter Inhibitors J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 720 - 727. [Abstract] [Full Text] [PDF]

				K. P. Lindsey, K. M. Wilcox, J. R. Votaw, M. M. Goodman, C. Plisson, F. I. Carroll, K. C. Rice, and L. L. Howell Effects of Dopamine Transporter Inhibitors on Cocaine Self-Administration in Rhesus Monkeys: Relationship to Transporter Occupancy Determined by Positron Emission Tomography Neuroimaging J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 959 - 969. [Abstract] [Full Text] [PDF]

				W. L. Woolverton, R. Ranaldi, Z. Wang, G. A. Ordway, I. A. Paul, P. Petukhov, and A. Kozikowski Reinforcing Strength of a Novel Dopamine Transporter Ligand: Pharmacodynamic and Pharmacokinetic Mechanisms J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 211 - 217. [Abstract] [Full Text] [PDF]

				C. Drouin, L. Darracq, F. Trovero, G. Blanc, J. Glowinski, S. Cotecchia, and J.-P. Tassin alpha 1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates J. Neurosci., April 1, 2002; 22(7): 2873 - 2884. [Abstract] [Full Text] [PDF]

				L. L. Howell and K. M. Wilcox The Dopamine Transporter and Cocaine Medication Development: Drug Self-Administration in Nonhuman Primates J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 1 - 6. [Abstract] [Full Text]

				J. Dunayer In the Name of Science: The Language of Vivisection Organization Environment, December 1, 2000; 13(4): 432 - 452. [PDF]

				L. L. Howell, P. W. Czoty, M. J. Kuhar, and F. I. Carrol Comparative Behavioral Pharmacology of Cocaine and the Selective Dopamine Uptake Inhibitor RTI-113 in the Squirrel Monkey J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 521 - 529. [Abstract] [Full Text]

				M. M. Knuepfer and Q. Gan Effects of Proposed Treatments for Cocaine Addiction on Hemodynamic Responsiveness to Cocaine in Conscious Rats J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 592 - 603. [Abstract] [Full Text]

				S. R. Tella, B. Ladenheim, A. M. Andrews, S. R. Goldberg, and J. L. Cadet Differential Reinforcing Effects of Cocaine and GBR-12909: Biochemical Evidence for Divergent Neuroadaptive Changes in the Mesolimbic Dopaminergic System J. Neurosci., December 1, 1996; 16(23): 7416 - 7427. [Abstract] [Full Text] [PDF]